Two Sigma Advisers’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-80,400
| Closed | -$3.23M | – | 2363 |
|
|
2025
Q1 | $3.23M | Sell |
80,400
-146,000
| -64% | -$5.87M | 0.01% | 962 |
|
|
2024
Q4 | $10.6M | Buy |
226,400
+11,700
| +5% | +$550K | 0.02% | 466 |
|
|
2024
Q3 | $11.3M | Buy |
+214,700
| New | +$11.3M | 0.03% | 459 |
|
|
2024
Q2 | – | Sell |
-7,000
| Closed | -$491K | – | 2493 |
|
|
2024
Q1 | $491K | Sell |
7,000
-76,800
| -92% | -$5.38M | ﹤0.01% | 1878 |
|
|
2023
Q4 | $7M | Sell |
83,800
-93,100
| -53% | -$7.77M | 0.02% | 670 |
|
|
2023
Q3 | $5.21M | Sell |
176,900
-101,500
| -36% | -$2.99M | 0.01% | 711 |
|
|
2023
Q2 | $9.08M | Sell |
278,400
-178,600
| -39% | -$5.83M | 0.02% | 525 |
|
|
2023
Q1 | $16.1M | Buy |
457,000
+2,000
| +0.4% | +$70.4K | 0.04% | 395 |
|
|
2022
Q4 | $20.8M | Buy |
455,000
+53,100
| +13% | +$2.43M | 0.06% | 327 |
|
|
2022
Q3 | $19.5M | Sell |
401,900
-62,500
| -13% | -$3.03M | 0.06% | 333 |
|
|
2022
Q2 | $18.2M | Sell |
464,400
-114,900
| -20% | -$4.51M | 0.05% | 343 |
|
|
2022
Q1 | $21.3M | Sell |
579,300
-199,800
| -26% | -$7.35M | 0.06% | 314 |
|
|
2021
Q4 | $35.5M | Sell |
779,100
-40,800
| -5% | -$1.86M | 0.09% | 196 |
|
|
2021
Q3 | $29.3M | Sell |
819,900
-57,100
| -7% | -$2.04M | 0.08% | 237 |
|
|
2021
Q2 | $17.4M | Sell |
877,000
-98,300
| -10% | -$1.95M | 0.05% | 370 |
|
|
2021
Q1 | $22.7M | Buy |
975,300
+221,200
| +29% | +$5.15M | 0.06% | 333 |
|
|
2020
Q4 | $15.7M | Sell |
754,100
-43,400
| -5% | -$902K | 0.04% | 413 |
|
|
2020
Q3 | $17.3M | Buy |
797,500
+70,300
| +10% | +$1.52M | 0.05% | 360 |
|
|
2020
Q2 | $17.1M | Buy |
727,200
+53,400
| +8% | +$1.26M | 0.05% | 368 |
|
|
2020
Q1 | $7.94M | Buy |
673,800
+153,000
| +29% | +$1.8M | 0.03% | 563 |
|
|
2019
Q4 | $5.53M | Buy |
520,800
+250,000
| +92% | +$2.65M | 0.01% | 808 |
|
|
2019
Q3 | $3.08M | Buy |
270,800
+14,300
| +6% | +$163K | 0.01% | 942 |
|
|
2019
Q2 | $2.89M | Buy |
256,500
+24,100
| +10% | +$271K | 0.01% | 1045 |
|
|
2019
Q1 | $1.88M | Buy |
232,400
+168,700
| +265% | +$1.36M | ﹤0.01% | 1248 |
|
|
2018
Q4 | $403K | Sell |
63,700
-3,200
| -5% | -$20.2K | ﹤0.01% | 1857 |
|
|
2018
Q3 | $659K | Sell |
66,900
-11,700
| -15% | -$115K | ﹤0.01% | 1687 |
|
|
2018
Q2 | $652K | Sell |
78,600
-5,400
| -6% | -$44.8K | ﹤0.01% | 1807 |
|
|
2018
Q1 | $605K | Buy |
84,000
+9,200
| +12% | +$66.3K | ﹤0.01% | 1752 |
|
|
2017
Q4 | $610K | Buy |
74,800
+28,800
| +63% | +$235K | ﹤0.01% | 1713 |
|
|
2017
Q3 | $667K | Buy |
46,000
+8,300
| +22% | +$120K | ﹤0.01% | 1637 |
|
|
2017
Q2 | $456K | Sell |
37,700
-2,800
| -7% | -$33.9K | ﹤0.01% | 1825 |
|
|
2017
Q1 | $520K | Sell |
40,500
-8,900
| -18% | -$114K | ﹤0.01% | 1879 |
|
|
2016
Q4 | $600K | Sell |
49,400
-40,300
| -45% | -$489K | ﹤0.01% | 1773 |
|
|
2016
Q3 | $823K | Buy |
89,700
+45,800
| +104% | +$420K | ﹤0.01% | 1453 |
|
|
2016
Q2 | $417K | Sell |
43,900
-23,300
| -35% | -$221K | ﹤0.01% | 1593 |
|
|
2016
Q1 | $474K | Sell |
67,200
-11,395
| -14% | -$80.4K | ﹤0.01% | 1482 |
|
|
2015
Q4 | $822K | Buy |
78,595
+66,493
| +549% | +$695K | ﹤0.01% | 1112 |
|
|
2015
Q3 | $81K | Buy |
+12,102
| New | +$81K | ﹤0.01% | 1733 |
|